In the original article, there was an error. Several words were omitted in the first sentence of a paragraph which altered the meaning of a sentence. A correction has been made to the section the Development of Tissue-Specific or Tissue-Resident NK Cells and Helper ILC1s, subsection Liver, paragraph 2. The corrected paragraph appears below:
“Phenotypically, liver ILC1s resemble immature cNKs in having low or no expression of killer cell lectin-like receptor G1 (KLRG1), CD11b, CD122, and Ly49 receptors such as Ly49A, Ly49D, Ly49G2, and Ly49H (50, 51, 63, 64). However, liver ILC1s are transcriptomically distinct from both immature and mature cNKs and exhibit an activated phenotype at steady state, characterized by high expression of CD69, CD44, and CD160, and low expression of CD62L (also known as L-selectin) (51, 59, 64, 65). They also express high levels of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and CD127, as well as chemokine receptors such as CXCR3 and CXCR6 that support residence in the liver sinusoids (50, 51, 59, 64, 66, 67). Although activated liver ILC1s retain cytotoxic functionality against target cells, they differ from cNKs in their higher production of TNF-α, IL-2, and granulocyte-macrophage colony-stimulating factor (GM-CSF), their preferential expression of granzyme C instead of granzyme B, and their reduced expression of perforin (51, 59, 64, 65). Liver ILC1s also express molecules involved in immune regulation, including PD-L1, LAG3, CD39, and CD73, and were recently shown to inhibit T cell function via the PD-1–PD-L1 axis (68).”
The authors apologize for this error and state that this does not change the key scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
natural killer cells, tissue-resident NK cells, transcriptional regulation, transcription factors, group 1 innate lymphoid cells
Citation
Valero-Pacheco N and Beaulieu AM (2020) Corrigendum: Transcriptional Regulation of Mouse Tissue-Resident Natural Killer Cell Development. Front. Immunol. 11:1355. doi: 10.3389/fimmu.2020.01355
Received
26 May 2020
Accepted
27 May 2020
Published
08 July 2020
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
11 - 2020
Updates
Copyright
© 2020 Valero-Pacheco and Beaulieu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Aimee M. Beaulieu ab1550@njms.rutgers.edu
This article was submitted to NK and Innate Lymphoid Cell Biology, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.